{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T07:33:28Z","timestamp":1763019208200,"version":"3.45.0"},"reference-count":17,"publisher":"Begell House","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Long Term Eff Med Implants"],"published-print":{"date-parts":[[2025]]},"abstract":"<p>Biomarkers within peri-implant crevicular fluid (PICF) are emerging as pivotal diagnostic agents, promising heightened accuracy in identifying peri-implant diseases. The present study aimed to assess the impact of non-sur-gical therapy on PICF calprotectin levels in patients with peri-implantitis. A total of 40 individuals aged between 30 and 60 years were enrolled: Group I (&lt;i&gt;n&lt;\/i&gt; &amp;#61;  20 healthy peri-implant sites) and Group IIa (&lt;i&gt;n&lt;\/i&gt; &amp;#61; 20 peri-implantitis sites). Clinical parameters such as peri-implant probing depth (PPD) and clinical attachment level (CAL) were recorded. PICF samples were collected and assayed for calprotectin using enzyme-linked immunosorbent assay (ELISA). After clinical examination and PICF collection at baseline, mechanical debridement was done for peri-implantitis patients, and after 3 months, clinical examination and PICF collection was done (Group IIb). The results were statistically analyzed. The PICF calprotectin level was higher in Group IIa (43.76 &amp;#177; 3.64 ng\/mL) as compared with Group I (11.36 &amp;#177;2.53 ng\/mL). Between Groups IIa and IIb, there was a significant reduction in PPD, CAL, and calprotectin from baseline to 3 months (&lt;i&gt;P&lt;\/i&gt; &amp;#60; 0.05). Pearson correlation in Groups IIa and IIb revealed that the correlation between calprotectin and clinical parameters was strongly positive and statistically significant. The present study suggests that there was a significant reduction in PICF calprotectin levels among peri-implantitis patients after mechanical debridement. Also, there exists a positive correlation between PICF calprotectin and peri-implant health parameters.<\/p>","DOI":"10.1615\/jlongtermeffmedimplants.2025057382","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T11:22:13Z","timestamp":1749208933000},"page":"15-20","source":"Crossref","is-referenced-by-count":0,"title":["Unlocking Healing Potential: Impact of Non-Surgical Therapy on Peri-Implant Crevicular Fluid Calprotectin Levels - A Clinical Insight"],"prefix":"10.1615","volume":"35","author":[{"given":"Ritvija","family":"Cinderella","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arvina","family":"Rajasekar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"613","reference":[{"key":"2","doi-asserted-by":"crossref","unstructured":"Yadalam PK, Sharma S, Natarajan PM, Ardila CM. Gradient boosting-based classification of interactome hub genes in periimplantitis with periodontitis-An integrated bioinformatic approach. Front Oral Health. 2024;5:1462845.","DOI":"10.3389\/froh.2024.1462845"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Sri HK, Ahmed N, Sasanka LK. Association of age, gender, and site of implant placement: An institution-based retrospective study. J Long Term Eff Med Implants. 2024;34(3):75-82.","DOI":"10.1615\/JLongTermEffMedImplants.2023039184"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Yadalam PK, Ardila CM. Deep neural networks based on sp7 protein sequence prediction in peri\u00e2\u0080\u0090implant bone formation. Int J Dent. 2025;2025(1):7583275.","DOI":"10.1155\/ijod\/7583275"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Sagar S, Ramani P, Moses S, Gheena S, Selvaraj J. Correlation of salivary cytokine IL-17A and 1, 25 dihydroxycholecalciferol in patients undergoing orthodontic treatment. Odontology. 2024;112(3):966-75.","DOI":"10.1007\/s10266-023-00890-1"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Jukic A, Bakiri L, Wagner EF, Tilg H, Adolph TE. Calprotectin: From biomarker to biological function. Gut. 2021;70(10):1978-88.","DOI":"10.1136\/gutjnl-2021-324855"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Nakamura T, Kido JI, Kido R, Ohishi K, Yamauchi N, Kataoka M, Nagata T. The association of calprotectin level in gingival crevicular fluid with gingival index and the activities of collagenase and aspartate aminotransferase in adult periodontitis patients. J Periodontol. 2000;71(3):361-7.","DOI":"10.1902\/jop.2000.71.3.361"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Wei L, Liu M, Xiong H. Role of calprotectin as a biomarker in periodontal disease. Mediat Inflamm. 2019; 2019(1):3515026.","DOI":"10.1155\/2019\/3515026"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Delucchi F, Canepa C, Canullo L, Pesce P, Isola G, Menini M. Biomarkers from peri-implant crevicular fluid (PICF) as predictors of peri-implant bone loss: A systematic review. Int J Mol Sci. 2023;24(4):3202.","DOI":"10.3390\/ijms24043202"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Renvert S, Persson GR, Pirih FQ, Camargo PM. Peri-implant health, peri-implant mucositis, and peri-implantitis: Case definitions and diagnostic considerations. J Clin Periodontol. 2018;45:S278-85.","DOI":"10.1111\/jcpe.12956"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Lumbikananda S, Srithanyarat SS, Mattheos N, Osathanon T. Oral fluid biomarkers for peri-implantitis: A scoping review. Int Dent J. 2024;74(3):387-402.","DOI":"10.1016\/j.identj.2023.11.005"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Priyadharsini KS, Rajasekar A. Comparative evaluation of C-reactive protein levels among peri-implant health and disease conditions. J Long Term Eff Med Implants. 2024;34(3):19-22.","DOI":"10.1615\/JLongTermEffMedImplants.2023047435"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Rithanya M, Rajasekar A. Comparative assessment of catalase levels in peri-implant health and disease. J Long Term Eff Med Implants. 2024;34(3):9-12.","DOI":"10.1615\/JLongTermEffMedImplants.2023047580"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Striz I, Trebichavsk\u00fd I. Calprotectin-a pleiotropic molecule in acute and chronic inflammation. Physiol Res. 2004;53:245-53.","DOI":"10.33549\/physiolres.930448"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Sakamoto E, Kido R, Tomotake Y, Naitou Y, Ishida Y, Kido JI. Calprotectin and cross-linked N-telopeptides of type I collagen levels in crevicular fluid from implant sites with peri-implant diseases: A pilot study. Int J Implant Dent. 2018;4:1-8.","DOI":"10.1186\/s40729-018-0138-2"},{"key":"16","doi-asserted-by":"crossref","unstructured":"\u00d6nder YB, Alpaslan NZ. Peri-implant phenotype, calprotectin and MMP-8 levels in cases diagnosed with peri-implant disease. Clin Oral Invest. 2024;28(7):404-9.","DOI":"10.1007\/s00784-024-05798-w"},{"key":"17","unstructured":"Kalia P, Mushtaq S, Sharma SK, Sharma P, Kaushal P. Evaluation of calprotectin levels in crevicular fluid from implant sites in patients with peri-implantitis. Int J Appl Dent Sci. 2020;6(3):109-11."},{"key":"18","doi-asserted-by":"crossref","unstructured":"Kido R, Kido JI, Nishikawa Y, Sakamoto E, Tomotake Y, Yumoto H. Diagnosis of inflammatory peri-implant diseases using an immunochromatographic assay for calprotectin in peri-implant crevicular fluid. Int J Implant Dent. 2021;7:1-8.","DOI":"10.1186\/s40729-021-00386-z"}],"container-title":["Journal of Long-Term Effects of Medical Implants"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dl.begellhouse.com\/download\/article\/39a936e649cacdc5\/JLT-57382.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T07:29:00Z","timestamp":1763018940000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dl.begellhouse.com\/journals\/1bef42082d7a0fdf,103b9c021ad8c265,39a936e649cacdc5.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1615\/jlongtermeffmedimplants.2025057382","relation":{},"ISSN":["1050-6934"],"issn-type":[{"type":"print","value":"1050-6934"}],"subject":[],"published":{"date-parts":[[2025]]}}}